These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND uPA AND Treatment
33 results:

  • 1. Association between circulating inflammatory proteins and benign prostatic disease: a Mendelian randomization study.
    Cao H; Shi C; Aihemaiti Z; Dai X; Wang F; Wang S
    Sci Rep; 2024 Oct; 14(1):23667. PubMed ID: 39390078
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma.
    Bønløkke ST; Fenger-Eriksen C; Ommen HB; Hvas AM
    Blood Adv; 2023 Nov; 7(22):7056-7066. PubMed ID: 37756519
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Amentoflavone Induces Apoptosis and Reduces Expression of Anti-apoptotic and Metastasis-associated Proteins in Bladder Cancer.
    Chiang CH; Yeh CY; Chung JG; Chiang IT; Hsu FT
    Anticancer Res; 2019 Jul; 39(7):3641-3649. PubMed ID: 31262890
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Characteristics of fibrinolytic disorders in acute promyelocytic leukemia.
    Wang P; Zhang Y; Yang H; Hou W; Jin B; Hou J; Li H; Zhao H; Zhou J
    Hematology; 2018 Dec; 23(10):756-764. PubMed ID: 29724147
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
    Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
    Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
    Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Development of novel therapeutics targeting the urokinase plasminogen activator receptor (upaR) and their translation toward the clinic.
    Mazar AP; Ahn RW; O'Halloran TV
    Curr Pharm Des; 2011; 17(19):1970-8. PubMed ID: 21711234
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.
    Dar A; Schajnovitz A; Lapid K; Kalinkovich A; Itkin T; Ludin A; Kao WM; Battista M; Tesio M; Kollet O; Cohen NN; Margalit R; Buss EC; Baleux F; Oishi S; Fujii N; Larochelle A; Dunbar CE; Broxmeyer HE; Frenette PS; Lapidot T
    Leukemia; 2011 Aug; 25(8):1286-1296. PubMed ID: 21494253
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical and molecular features of papillary thyroid cancer in adolescents and young adults.
    Vriens MR; Moses W; Weng J; Peng M; Griffin A; Bleyer A; Pollock BH; Indelicato DJ; Hwang J; Kebebew E
    Cancer; 2011 Jan; 117(2):259-67. PubMed ID: 20824721
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy.
    Wu JM; Sheng H; Saxena R; Skill NJ; Bhat-Nakshatri P; Yu M; Nakshatri H; Maluccio MA
    Cancer Lett; 2009 Jun; 278(2):145-155. PubMed ID: 19303700
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring.
    Wang XD; Reeves K; Luo FR; Xu LA; Lee F; Clark E; Huang F
    Genome Biol; 2007; 8(11):R255. PubMed ID: 18047674
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart.
    Weiss TW; Kvakan H; Kaun C; Zorn G; Speidl WS; Pfaffenberger S; Maurer G; Huber K; Wojta J
    J Mol Cell Cardiol; 2005 Sep; 39(3):545-51. PubMed ID: 15890357
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF.
    Langer F; Amirkhosravi A; Loges S; Meyer T; Eifrig B; Hossfeld DK; Fiedler W; Francis JL
    Thromb Haemost; 2004 Nov; 92(5):1136-46. PubMed ID: 15543344
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.
    Tallman MS; Lefèbvre P; Baine RM; Shoji M; Cohen I; Green D; Kwaan HC; Paietta E; Rickles FR
    J Thromb Haemost; 2004 Aug; 2(8):1341-50. PubMed ID: 15304040
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts.
    Abi-Habib RJ; Liu S; Bugge TH; Leppla SH; Frankel AE
    Blood; 2004 Oct; 104(7):2143-8. PubMed ID: 15161668
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion.
    Aref S; El-Sherbiny M; Mabed M; Menessy A; El-Refaei M
    Hematology; 2003 Dec; 8(6):385-91. PubMed ID: 14668033
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. SRC family kinases: potential targets for the treatment of human cancer and leukemia.
    Warmuth M; Damoiseaux R; Liu Y; Fabbro D; Gray N
    Curr Pharm Des; 2003; 9(25):2043-59. PubMed ID: 14529415
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells.
    Ramage JG; Vallera DA; Black JH; Aplan PD; Kees UR; Frankel AE
    Leuk Res; 2003 Jan; 27(1):79-84. PubMed ID: 12479856
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Clinical significance of hemostatic molecular markers in acute leukemia].
    Wu F; Wang X; Qu B; Huang X; Wang H
    Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):141-4. PubMed ID: 11877066
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Matrix and serine protease expression during leukemic cell differentiation induced by aclacinomycin and all-trans-retinoic acid.
    Devy L; Hollender P; Munaut C; Colige A; Garnotel R; Foidart JM; Noël A; Jeannesson P
    Biochem Pharmacol; 2002 Jan; 63(2):179-89. PubMed ID: 11841792
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 2.